
LINK . SPRINGER . COM {
}
Title:
Inhibition of Nuclear Factor-κB Enhances the Antitumor Effect of Paclitaxel Against Gastric Cancer with Peritoneal Dissemination in Mice | Digestive Diseases and Sciences
Description:
Intraperitoneal (i.p.) administration of paclitaxel is useful for treating malignant tumors with peritoneal dissemination, but the therapeutic efficacy is limited. Chemoresistance due to paclitaxel-induced nuclear factor-kappa B (NF-κB) activation is an important cause of suboptimal therapeutic efficacy. The purpose of this study was to prove that addition of nafamostat mesilate (FUT-175), a synthetic serine protease inhibitor and an NF-κB inhibitor, to i.p. paclitaxel enhances antitumor effects of paclitaxel against gastric cancer with peritoneal dissemination. In vitro, we assessed NF-κB activity and apoptosis in response to treatment with FUT-175 alone, paclitaxel alone, or a combination of FUT-175 and paclitaxel in a human gastric cancer cell line (MKN-45). In vivo, we established peritoneal dissemination in nude mice by i.p. injection of MKN-45 cells. The animals received i.p. injections of FUT-175 alone three times a week (FUT-175 group), of paclitaxel alone once a week (paclitaxel group), or a combination of FUT-175 and paclitaxel (combination group) three times and once a week, respectively. In the combination group, paclitaxel-induced NF-κB activation was inhibited and apoptosis was enhanced in comparison with those in the other groups both in vitro and in vivo. In the combination group, number and weight of peritoneal nodules were significantly lower than those in the paclitaxel group (p = 0.0009 and p = 0.0417, respectively). In the survival analysis, the combination group had a significantly better survival than the paclitaxel group (p = 0.0048). FUT-175 enhances the antitumor effect of i.p. paclitaxel against gastric cancer with peritoneal dissemination by inhibiting NF-κB activation in mice.
Website Age:
28 years and 1 months (reg. 1997-05-29).
Matching Content Categories {📚}
- Education
- Science
- Social Networks
Content Management System {📝}
What CMS is link.springer.com built with?
Custom-built
No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.
Traffic Estimate {📈}
What is the average monthly size of link.springer.com audience?
🌠 Phenomenal Traffic: 5M - 10M visitors per month
Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Link.springer.com Make Money? {💸}
We can't figure out the monetization strategy.
Not every website is profit-driven; some are created to spread information or serve as an online presence. Websites can be made for many reasons. This could be one of them. Link.springer.com might be plotting its profit, but the way they're doing it isn't detectable yet.
Keywords {🔍}
google, scholar, pubmed, article, cas, cancer, paclitaxel, gastric, nuclear, peritoneal, nfkappab, cell, fut, res, combination, human, pancreatic, inhibition, dissemination, intraperitoneal, activation, nafamostat, mesilate, group, carcinoma, antitumor, mice, inhibitor, apoptosis, cells, factor, enhances, uwagawa, access, chemotherapy, clin, privacy, cookies, content, haruki, fujiwara, furukawa, paclitaxelinduced, nfκb, study, vitro, resistance, taxol, oncol, factorkappab,
Topics {✒️}
paclitaxel-induced nuclear factor-kappa month download article/chapter inhibiting nf-κb activation paclitaxel-induced nf-κb activation nuclear factor-κb enhances tnf-alpha-induced apoptosis nuclear factor-kappab p65 ryota iwase & toya ohashi assessed nf-κb activity article digestive diseases gemcitabine-induced cell death constitutively active nf-kappab nuclear factor kappa nuclear factor-kappa nuclear factor-kappab nuclear factor kappab full article pdf enhanced anti-tumor therapy nf-kappab activation privacy choices/manage cookies cell growth regulation nf-κb inhibitor mediated cell death nf-kappab complexes nf-kappab antiapoptosis paclitaxel-induced apoptosis human breast cancer reveals cell cycle advanced gastric carcinoma pathological complete response breast cancer cells systemic combined chemotherapy intraperitoneal paclitaxel combined intraperitoneal antineoplastic agents suppress caspase-8 activation synthetic protease inhibitor taxol-induced polymerization inhibits lung metastasis taxol-induced apoptosis advanced gastric cancer anti-tumor effect established peritoneal dissemination check access instant access advanced pancreatic cancer rela transcription factor european economic area treating malignant tumors suboptimal therapeutic efficacy ikappabalpha super-repressor
Schema {🗺️}
WebPage:
mainEntity:
headline:Inhibition of Nuclear Factor-κB Enhances the Antitumor Effect of Paclitaxel Against Gastric Cancer with Peritoneal Dissemination in Mice
description:Intraperitoneal (i.p.) administration of paclitaxel is useful for treating malignant tumors with peritoneal dissemination, but the therapeutic efficacy is limited. Chemoresistance due to paclitaxel-induced nuclear factor-kappa B (NF-κB) activation is an important cause of suboptimal therapeutic efficacy. The purpose of this study was to prove that addition of nafamostat mesilate (FUT-175), a synthetic serine protease inhibitor and an NF-κB inhibitor, to i.p. paclitaxel enhances antitumor effects of paclitaxel against gastric cancer with peritoneal dissemination. In vitro, we assessed NF-κB activity and apoptosis in response to treatment with FUT-175 alone, paclitaxel alone, or a combination of FUT-175 and paclitaxel in a human gastric cancer cell line (MKN-45). In vivo, we established peritoneal dissemination in nude mice by i.p. injection of MKN-45 cells. The animals received i.p. injections of FUT-175 alone three times a week (FUT-175 group), of paclitaxel alone once a week (paclitaxel group), or a combination of FUT-175 and paclitaxel (combination group) three times and once a week, respectively. In the combination group, paclitaxel-induced NF-κB activation was inhibited and apoptosis was enhanced in comparison with those in the other groups both in vitro and in vivo. In the combination group, number and weight of peritoneal nodules were significantly lower than those in the paclitaxel group (p = 0.0009 and p = 0.0417, respectively). In the survival analysis, the combination group had a significantly better survival than the paclitaxel group (p = 0.0048). FUT-175 enhances the antitumor effect of i.p. paclitaxel against gastric cancer with peritoneal dissemination by inhibiting NF-κB activation in mice.
datePublished:2012-07-18T00:00:00Z
dateModified:2012-07-18T00:00:00Z
pageStart:123
pageEnd:131
sameAs:https://doi.org/10.1007/s10620-012-2311-4
keywords:
Nafamostat mesilate
Paclitaxel
Gastric cancer
Peritoneal dissemination
Intraperitoneal chemotherapy
Gastroenterology
Hepatology
Oncology
Transplant Surgery
Biochemistry
general
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10620-012-2311-4/MediaObjects/10620_2012_2311_Fig1_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10620-012-2311-4/MediaObjects/10620_2012_2311_Fig2_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10620-012-2311-4/MediaObjects/10620_2012_2311_Fig3_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10620-012-2311-4/MediaObjects/10620_2012_2311_Fig4_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10620-012-2311-4/MediaObjects/10620_2012_2311_Fig5_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10620-012-2311-4/MediaObjects/10620_2012_2311_Fig6_HTML.jpg
isPartOf:
name:Digestive Diseases and Sciences
issn:
1573-2568
0163-2116
volumeNumber:58
type:
Periodical
PublicationVolume
publisher:
name:Springer US
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Koichiro Haruki
affiliation:
name:The Jikei University School of Medicine
address:
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
name:The Jikei University School of Medicine
address:
name:Department of Gene Therapy, Institute of DNA Medicine, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:Hiroaki Shiba
affiliation:
name:The Jikei University School of Medicine
address:
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
type:Person
name:Yuki Fujiwara
affiliation:
name:The Jikei University School of Medicine
address:
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
name:The Jikei University School of Medicine
address:
name:Department of Gene Therapy, Institute of DNA Medicine, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
type:Person
name:Kenei Furukawa
affiliation:
name:The Jikei University School of Medicine
address:
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
type:Person
name:Ryota Iwase
affiliation:
name:The Jikei University School of Medicine
address:
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
name:The Jikei University School of Medicine
address:
name:Department of Gene Therapy, Institute of DNA Medicine, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
type:Person
name:Tadashi Uwagawa
affiliation:
name:The Jikei University School of Medicine
address:
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
type:Person
name:Takeyuki Misawa
affiliation:
name:The Jikei University School of Medicine
address:
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
type:Person
name:Toya Ohashi
affiliation:
name:The Jikei University School of Medicine
address:
name:Department of Gene Therapy, Institute of DNA Medicine, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
type:Person
name:Katsuhiko Yanaga
affiliation:
name:The Jikei University School of Medicine
address:
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:Inhibition of Nuclear Factor-κB Enhances the Antitumor Effect of Paclitaxel Against Gastric Cancer with Peritoneal Dissemination in Mice
description:Intraperitoneal (i.p.) administration of paclitaxel is useful for treating malignant tumors with peritoneal dissemination, but the therapeutic efficacy is limited. Chemoresistance due to paclitaxel-induced nuclear factor-kappa B (NF-κB) activation is an important cause of suboptimal therapeutic efficacy. The purpose of this study was to prove that addition of nafamostat mesilate (FUT-175), a synthetic serine protease inhibitor and an NF-κB inhibitor, to i.p. paclitaxel enhances antitumor effects of paclitaxel against gastric cancer with peritoneal dissemination. In vitro, we assessed NF-κB activity and apoptosis in response to treatment with FUT-175 alone, paclitaxel alone, or a combination of FUT-175 and paclitaxel in a human gastric cancer cell line (MKN-45). In vivo, we established peritoneal dissemination in nude mice by i.p. injection of MKN-45 cells. The animals received i.p. injections of FUT-175 alone three times a week (FUT-175 group), of paclitaxel alone once a week (paclitaxel group), or a combination of FUT-175 and paclitaxel (combination group) three times and once a week, respectively. In the combination group, paclitaxel-induced NF-κB activation was inhibited and apoptosis was enhanced in comparison with those in the other groups both in vitro and in vivo. In the combination group, number and weight of peritoneal nodules were significantly lower than those in the paclitaxel group (p = 0.0009 and p = 0.0417, respectively). In the survival analysis, the combination group had a significantly better survival than the paclitaxel group (p = 0.0048). FUT-175 enhances the antitumor effect of i.p. paclitaxel against gastric cancer with peritoneal dissemination by inhibiting NF-κB activation in mice.
datePublished:2012-07-18T00:00:00Z
dateModified:2012-07-18T00:00:00Z
pageStart:123
pageEnd:131
sameAs:https://doi.org/10.1007/s10620-012-2311-4
keywords:
Nafamostat mesilate
Paclitaxel
Gastric cancer
Peritoneal dissemination
Intraperitoneal chemotherapy
Gastroenterology
Hepatology
Oncology
Transplant Surgery
Biochemistry
general
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10620-012-2311-4/MediaObjects/10620_2012_2311_Fig1_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10620-012-2311-4/MediaObjects/10620_2012_2311_Fig2_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10620-012-2311-4/MediaObjects/10620_2012_2311_Fig3_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10620-012-2311-4/MediaObjects/10620_2012_2311_Fig4_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10620-012-2311-4/MediaObjects/10620_2012_2311_Fig5_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10620-012-2311-4/MediaObjects/10620_2012_2311_Fig6_HTML.jpg
isPartOf:
name:Digestive Diseases and Sciences
issn:
1573-2568
0163-2116
volumeNumber:58
type:
Periodical
PublicationVolume
publisher:
name:Springer US
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Koichiro Haruki
affiliation:
name:The Jikei University School of Medicine
address:
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
name:The Jikei University School of Medicine
address:
name:Department of Gene Therapy, Institute of DNA Medicine, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:Hiroaki Shiba
affiliation:
name:The Jikei University School of Medicine
address:
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
type:Person
name:Yuki Fujiwara
affiliation:
name:The Jikei University School of Medicine
address:
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
name:The Jikei University School of Medicine
address:
name:Department of Gene Therapy, Institute of DNA Medicine, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
type:Person
name:Kenei Furukawa
affiliation:
name:The Jikei University School of Medicine
address:
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
type:Person
name:Ryota Iwase
affiliation:
name:The Jikei University School of Medicine
address:
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
name:The Jikei University School of Medicine
address:
name:Department of Gene Therapy, Institute of DNA Medicine, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
type:Person
name:Tadashi Uwagawa
affiliation:
name:The Jikei University School of Medicine
address:
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
type:Person
name:Takeyuki Misawa
affiliation:
name:The Jikei University School of Medicine
address:
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
type:Person
name:Toya Ohashi
affiliation:
name:The Jikei University School of Medicine
address:
name:Department of Gene Therapy, Institute of DNA Medicine, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
type:Person
name:Katsuhiko Yanaga
affiliation:
name:The Jikei University School of Medicine
address:
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
["Periodical","PublicationVolume"]:
name:Digestive Diseases and Sciences
issn:
1573-2568
0163-2116
volumeNumber:58
Organization:
name:Springer US
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:The Jikei University School of Medicine
address:
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
name:The Jikei University School of Medicine
address:
name:Department of Gene Therapy, Institute of DNA Medicine, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
name:The Jikei University School of Medicine
address:
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
name:The Jikei University School of Medicine
address:
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
name:The Jikei University School of Medicine
address:
name:Department of Gene Therapy, Institute of DNA Medicine, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
name:The Jikei University School of Medicine
address:
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
name:The Jikei University School of Medicine
address:
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
name:The Jikei University School of Medicine
address:
name:Department of Gene Therapy, Institute of DNA Medicine, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
name:The Jikei University School of Medicine
address:
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
name:The Jikei University School of Medicine
address:
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
name:The Jikei University School of Medicine
address:
name:Department of Gene Therapy, Institute of DNA Medicine, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
name:The Jikei University School of Medicine
address:
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:Koichiro Haruki
affiliation:
name:The Jikei University School of Medicine
address:
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
name:The Jikei University School of Medicine
address:
name:Department of Gene Therapy, Institute of DNA Medicine, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
email:[email protected]
name:Hiroaki Shiba
affiliation:
name:The Jikei University School of Medicine
address:
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
name:Yuki Fujiwara
affiliation:
name:The Jikei University School of Medicine
address:
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
name:The Jikei University School of Medicine
address:
name:Department of Gene Therapy, Institute of DNA Medicine, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
name:Kenei Furukawa
affiliation:
name:The Jikei University School of Medicine
address:
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
name:Ryota Iwase
affiliation:
name:The Jikei University School of Medicine
address:
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
name:The Jikei University School of Medicine
address:
name:Department of Gene Therapy, Institute of DNA Medicine, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
name:Tadashi Uwagawa
affiliation:
name:The Jikei University School of Medicine
address:
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
name:Takeyuki Misawa
affiliation:
name:The Jikei University School of Medicine
address:
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
name:Toya Ohashi
affiliation:
name:The Jikei University School of Medicine
address:
name:Department of Gene Therapy, Institute of DNA Medicine, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
name:Katsuhiko Yanaga
affiliation:
name:The Jikei University School of Medicine
address:
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
PostalAddress:
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
name:Department of Gene Therapy, Institute of DNA Medicine, The Jikei University School of Medicine, Tokyo, Japan
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
name:Department of Gene Therapy, Institute of DNA Medicine, The Jikei University School of Medicine, Tokyo, Japan
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
name:Department of Gene Therapy, Institute of DNA Medicine, The Jikei University School of Medicine, Tokyo, Japan
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
name:Department of Gene Therapy, Institute of DNA Medicine, The Jikei University School of Medicine, Tokyo, Japan
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
WebPageElement:
isAccessibleForFree:
cssSelector:.main-content
External Links {🔗}(169)
- What is the monthly revenue of https://www.springernature.com/gp/authors?
- What are the total earnings of https://link.springernature.com/home/?
- Explore the financials of https://order.springer.com/public/cart
- How much profit is https://submission.springernature.com/new-submission/10620/3 making per month?
- How much money does https://www.springernature.com/gp/librarians/licensing/agc/journals make?
- Get to know http://scholar.google.com/scholar_lookup?&title=SEER%20cancer%20statistics%20review%2C%201975%E2%80%932000&publication_year=2003&author=Ries%2CL&author=Eisner%2CM&author=Kosary%2CC's earnings
- What's https://doi.org/10.1016%2FS0039-6060%2899%2970265-5's gross income?
- What's the monthly money flow for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10026754?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Expression%20of%20vascular%20endothelial%20growth%20factor%20correlates%20with%20hematogenous%20recurrence%20in%20gastric%20carcinoma&journal=Surgery&doi=10.1016%2FS0039-6060%2899%2970265-5&volume=125&pages=195-201&publication_year=1999&author=Saito%2CH&author=Tsujitani%2CS&author=Kondo%2CA bring in?
- What's the financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9689986?
- How much profit does http://scholar.google.com/scholar_lookup?&title=Phase%20II%20study%20of%20Taxol%20in%20patients%20with%20advanced%20gastric%20carcinoma&journal=Cancer%20J%20Sci%20Am&volume=4&pages=269-274&publication_year=1998&author=Ajani%2CJA&author=Fairweather%2CJ&author=Dumas%2CP generate?
- Find out how much http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=7915154 earns monthly
- http://scholar.google.com/scholar_lookup?&title=Update%20on%20the%20antitumor%20activity%20of%20pacitaxel%20in%20clinical%20trials&journal=Ann%20Pharmacother&volume=28&pages=S18-S22&publication_year=1994&author=Rowinsky%2CEK's revenue stream
- How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17633066 make?
- Income figures for http://scholar.google.com/scholar_lookup?&title=Cytoreduction%20and%20intraperitoneal%20chemotherapy%20for%20carcinomatosis%20from%20gastric%20cancer&journal=Cancer%20Treat%20Res&volume=134&pages=357-373&publication_year=2007&author=Yonemura%2CY&author=Bando%2CE&author=Kawamura%2CT
- What is the monthly revenue of https://doi.org/10.1093%2Fannonc%2Fmdp260?
- Find out how much http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19605503 earns monthly
- http://scholar.google.com/scholar_lookup?&title=Phase%20II%20study%20of%20weekly%20intravenous%20and%20intraperitoneal%20paclitaxel%20combined%20with%20S-1%20for%20advanced%20gastric%20cancer%20with%20peritoneal%20metastasis&journal=Ann%20Oncol&doi=10.1093%2Fannonc%2Fmdp260&volume=21&pages=67-70&publication_year=2010&author=Ishigami%2CH&author=Kitayama%2CJ&author=Kaisaki%2CS's total income per month
- How much does https://doi.org/10.1056%2FNEJMoa052985 pull in?
- How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16394300 make?
- What are the earnings of http://scholar.google.com/scholar_lookup?&title=Intraperitoneal%20cisplatin%20and%20paclitaxel%20in%20ovarian%20cancer&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJMoa052985&volume=354&pages=34-43&publication_year=2006&author=Armstrong%2CDK&author=Bundy%2CB&author=Wenzel%2CL?
- What is the monthly revenue of https://doi.org/10.1038%2Fsj.onc.1203768?
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10962577 produce monthly?
- Check the income stats for http://scholar.google.com/scholar_lookup?&title=Paclitaxel%20sensitivity%20of%20breast%20cancer%20cells%20with%20constitutively%20active%20NF-kappaB%20is%20enhanced%20by%20IkappaBalpha%20super-repressor%20and%20parthenolide&journal=Oncogene&doi=10.1038%2Fsj.onc.1203768&volume=19&pages=4159-4169&publication_year=2000&author=Patel%2CNM&author=Nozaki%2CS&author=Shortle%2CNH
- What are the total earnings of https://doi.org/10.1038%2Fsj.onc.1205848?
- What's the financial outcome of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12226754?
- How much money does http://scholar.google.com/scholar_lookup?&title=The%20function%20of%20multiple%20IkappaB%3A%20NF-kappaB%20complexes%20in%20the%20resistance%20of%20cancer%20cells%20to%20Taxol-induced%20apoptosis&journal=Oncogene&doi=10.1038%2Fsj.onc.1205848&volume=21&pages=6510-6519&publication_year=2002&author=Dong%2CQG&author=Sclabas%2CGM&author=Fujioka%2CS make?
- Discover the revenue of https://doi.org/10.1016%2FS0002-9440%2810%2961708-7
- Revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11485895
- http://scholar.google.com/scholar_lookup?&title=New%20insights%20into%20the%20role%20of%20nuclear%20factor-kappaB%20in%20cell%20growth%20regulation&journal=Am%20J%20Pathol&doi=10.1016%2FS0002-9440%2810%2961708-7&volume=159&pages=387-397&publication_year=2001&author=Chen%2CF&author=Castranova%2CV&author=Shi%2CX income
- Earnings of https://doi.org/10.1126%2Fscience.274.5288.782
- What's the financial outcome of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=8864118?
- How much does http://scholar.google.com/scholar_lookup?&title=An%20essential%20role%20for%20NF-kappaB%20in%20preventing%20TNF-alpha-induced%20cell%20death&journal=Science&doi=10.1126%2Fscience.274.5288.782&volume=274&pages=782-784&publication_year=1996&author=Beg%2CAA&author=Baltimore%2CD earn?
- How much money does https://doi.org/10.1126%2Fscience.274.5288.787 generate?
- How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=8864120 make?
- What's the monthly income of http://scholar.google.com/scholar_lookup?&title=Suppression%20of%20TNF-alpha-induced%20apoptosis%20by%20NF-kappaB&journal=Science&doi=10.1126%2Fscience.274.5288.787&volume=274&pages=787-789&publication_year=1996&author=Antwerp%2CDJ&author=Martin%2CSJ&author=Kafri%2CT?
- What are the earnings of https://doi.org/10.1038%2Fni0302-221?
- What's the total monthly financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11875461?
- Learn how profitable http://scholar.google.com/scholar_lookup?&title=NF-kappaB%20at%20the%20crossroads%20of%20life%20and%20death&journal=Nat%20Immunol&doi=10.1038%2Fni0302-221&volume=3&pages=221-227&publication_year=2002&author=Karin%2CM&author=Lin%2CA is on a monthly basis
- What's the financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11751513?
- How much profit does http://scholar.google.com/scholar_lookup?&title=Nuclear%20factor-kappaB%20p65%20%28RelA%29%20transcription%20factor%20is%20constitutively%20activated%20in%20human%20gastric%20carcinoma%20tissue&journal=Clin%20Cancer%20Res&volume=7&pages=4136-4142&publication_year=2001&author=Sasaki%2CN&author=Morisaki%2CT&author=Hashizume%2CK make?
- Explore the financials of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15154625
- Explore the financials of http://scholar.google.com/scholar_lookup?&title=Nuclear%20factor-kappaB%20p65%20is%20a%20prognostic%20indicator%20in%20gastric%20carcinoma&journal=Anticancer%20Res&volume=24&pages=1071-1075&publication_year=2004&author=Yamanaka%2CN&author=Sasaki%2CN&author=Tasaki%2CA
- How much income does https://doi.org/10.3748%2Fwjg.14.4739 have?
- What's the monthly money flow for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18720533?
- What's the financial outcome of http://scholar.google.com/scholar_lookup?&title=Nuclear%20factor%20kappa%20B%3A%20a%20marker%20of%20chemotherapy%20for%20human%20stage%20IV%20gastric%20carcinoma&journal=World%20J%20Gastroenterol&doi=10.3748%2Fwjg.14.4739&volume=14&pages=4739-4744&publication_year=2008&author=Long%2CYM&author=Ye%2CS&author=Rong%2CJ?
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9918209 income
- What's the financial intake of http://scholar.google.com/scholar_lookup?&title=The%20nuclear%20factor-kappa%20B%20RelA%20transcription%20factor%20is%20constitutively%20activated%20in%20human%20pancreatic%20adenocarcinoma%20cells&journal=Clin%20Cancer%20Res&volume=5&pages=119-127&publication_year=1999&author=Wang%2CW&author=Abbruzzese%2CJL&author=Evans%2CDB?
- How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12538487 generate?
- What's the financial intake of http://scholar.google.com/scholar_lookup?&title=Function%20of%20nuclear%20factor%20kappaB%20in%20pancreatic%20cancer%20metastasis&journal=Clin%20Cancer%20Res&volume=9&pages=346-354&publication_year=2003&author=Fujioka%2CS&author=Sclabas%2CGM&author=Schmidt%2CC?
- What's the financial intake of https://doi.org/10.1038%2F10577?
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10202930 produce monthly?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Control%20of%20inducible%20chemoresistance%3A%20enhanced%20anti-tumor%20therapy%20through%20increased%20apoptosis%20by%20inhibition%20of%20NF-kappaB&journal=Nat%20Med&doi=10.1038%2F10577&volume=5&pages=412-417&publication_year=1999&author=Wang%2CCY&author=Cusack%2CJC&author=Liu%2CR produce monthly?
- How much money does https://doi.org/10.1016%2FS0006-2952%2802%2900908-5 generate?
- What's http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11996883's gross income?
- http://scholar.google.com/scholar_lookup?&title=Increase%20of%20the%20resistance%20of%20human%20cervical%20carcinoma%20cells%20to%20cisplatin%20by%20inhibition%20of%20the%20MEK%20to%20ERK%20signaling%20pathway%20partly%20via%20enhancement%20of%20anticancer%20drug-induced%20NF%20kappa%20B%20activation&journal=Biochem%20Pharmacol&doi=10.1016%2FS0006-2952%2802%2900908-5&volume=63&pages=1423-1430&publication_year=2002&author=Yeh%2CPY&author=Chuang%2CSE&author=Yeh%2CKH's total income per month
- How much revenue does https://doi.org/10.1002%2Fijc.10972 bring in?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12584750 gross monthly?
- http://scholar.google.com/scholar_lookup?&title=Disulfiram-mediated%20inhibition%20of%20NF-kappaB%20activity%20enhances%20cytotoxicity%20of%205-fluorouracil%20in%20human%20colorectal%20cancer%20cell%20lines&journal=Int%20J%20Cancer&doi=10.1002%2Fijc.10972&volume=104&pages=504-511&publication_year=2003&author=Wang%2CW&author=McLeod%2CHL&author=Cassidy%2CJ's total income per month
- Check the income stats for https://doi.org/10.1038%2Fsj.onc.1206390
- How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12761494 make?
- http://scholar.google.com/scholar_lookup?&title=Role%20of%20NF-kappaB%20and%20Akt%2FPI3%C2%A0K%20in%20the%20resistance%20of%20pancreatic%20carcinoma%20cell%20lines%20against%20gemcitabine-induced%20cell%20death&journal=Oncogene&doi=10.1038%2Fsj.onc.1206390&volume=22&pages=3243-3251&publication_year=2003&author=Arlt%2CA&author=Gehrz%2CA&author=M%C3%BCerk%C3%B6ster%2CS income
- How much income does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11410792 have?
- Get to know what's the income of http://scholar.google.com/scholar_lookup?&title=Proteasome%20inhibitor%201%20enhances%20paclitaxel-induced%20apoptosis%20in%20human%20lung%20adenocarcinoma%20cell%20line&journal=Oncol%20Rep&volume=8&pages=825-829&publication_year=2001&author=Oyaizu%2CH&author=Adachi%2CY&author=Okumura%2CT
- How much cash flow does https://doi.org/10.1016%2F0005-2744%2881%2990023-1 have monthly?
- What's the profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=6271224?
- How much does http://scholar.google.com/scholar_lookup?&title=New%20synthetic%20inhibitors%20of%20C1r%2C%20C1%20esterase%2C%20thrombin%2C%20plasmin%2C%20kallikrein%20and%20trypsin&journal=Biochim%20Biophys%20Acta&doi=10.1016%2F0005-2744%2881%2990023-1&volume=661&pages=342-345&publication_year=1981&author=Fujii%2CS&author=Hitomi%2CY pull in monthly?
- What's the income generated by https://doi.org/10.1254%2Fjjp.35.203 each month?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=6482087 earn?
- What's the total monthly financial gain of http://scholar.google.com/scholar_lookup?&title=Pharmacological%20studies%20of%20FUT-175%2C%20nafamstat%20mesilate.%20I.%20Inhibition%20of%20protease%20activity%20in%20in%20vitro%20and%20in%20vivo%20experiments&journal=Jpn%20J%20Pharmacol&doi=10.1254%2Fjjp.35.203&volume=35&pages=203-227&publication_year=1984&author=Aoyama%2CT&author=Ino%2CY&author=Ozeki%2CM?
- How profitable is https://doi.org/10.1254%2Fjjp.41.155?
- Income figures for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=2427760
- How much money does http://scholar.google.com/scholar_lookup?&title=Pharmacological%20studies%20of%20FUT-175%2C%20nafamostat%20mesilate.%20V.%20Effects%20on%20the%20pancreatic%20enzymes%20and%20experimental%20acute%20pancreatitis%20in%20rats&journal=Jpn%20J%20Pharmacol&doi=10.1254%2Fjjp.41.155&volume=41&pages=155-162&publication_year=1986&author=Iwaki%2CM&author=Ino%2CY&author=Motoyoshi%2CA generate?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=6667905 gross monthly?
- See how much http://scholar.google.com/scholar_lookup?&title=Effects%20of%20FUT-175%2C%20a%20new%20synthetic%20protease%20inhibitor%20on%20endotoxin-induced%20disseminated%20intravascular%20coagulation%20in%20rats&journal=Haemostasis&volume=13&pages=374-378&publication_year=1983&author=Yoshikawa%2CT&author=Murakami%2CM&author=Furukawa%2CY makes per month
- What's http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=1666354's gross income?
- What's http://scholar.google.com/scholar_lookup?&title=Nafamostat%20mesylate%20as%20anticoagulant%20in%20continuous%20hemofiltration%20and%20continuous%20hemodiafiltration&journal=Contrib%20Nephrol&volume=93&pages=215-217&publication_year=1991&author=Ohtake%2CY&author=Hirasawa%2CH&author=Sugai%2CT's gross income?
- How much does https://doi.org/10.1002%2Fcncr.22658 earn?
- How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17410536 generate?
- How much does http://scholar.google.com/scholar_lookup?&title=Mechanisms%20of%20synthetic%20serine%20protease%20inhibitor%20%28FUT-175%29-mediated%20cell%20death&journal=Cancer&doi=10.1002%2Fcncr.22658&volume=109&pages=2142-2153&publication_year=2007&author=Uwagawa%2CT&author=Li%2CZ&author=Chang%2CZ gross monthly?
- How much does https://doi.org/10.3892%2For.2010.843 net monthly?
- What's the profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20811662?
- Profit of http://scholar.google.com/scholar_lookup?&title=Anti-tumor%20effect%20by%20inhibition%20of%20NF-kappaB%20activation%20using%20nafamostat%20mesilate%20for%20pancreatic%20cancer%20in%20a%20mouse%20model&journal=Oncol%20Rep&doi=10.3892%2For.2010.843&volume=24&pages=843-850&publication_year=2010&author=Furukawa%2CK&author=Iida%2CT&author=Shiba%2CH
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19661331 rake in every month?
- How much cash flow does http://scholar.google.com/scholar_lookup?&title=Combination%20chemotherapy%20of%20nafamostat%20mesilate%20with%20gemcitabine%20for%20pancreatic%20cancer%20targeting%20NF-kappaB%20activation&journal=Anticancer%20Res&volume=29&pages=3173-3178&publication_year=2009&author=Uwagawa%2CT&author=Chiao%2CPJ&author=Gocho%2CT have monthly?
- https://doi.org/10.1093%2Fannonc%2Fmdn640's revenue stream
- Get to know what's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18836085
- Earnings of http://scholar.google.com/scholar_lookup?&title=A%20phase%20I%20study%20of%20full-dose%20gemcitabine%20and%20regional%20arterial%20infusion%20of%20nafamostat%20mesilate%20for%20advanced%20pancreatic%20cancer&journal=Ann%20Oncol&doi=10.1093%2Fannonc%2Fmdn640&volume=20&pages=239-243&publication_year=2009&author=Uwagawa%2CT&author=Misawa%2CT&author=Sakamoto%2CT
- Learn how profitable https://doi.org/10.1097/COC.0b013e31823a53b2 is on a monthly basis
- How much does http://scholar.google.com/scholar_lookup?&title=Phase%20II%20study%20of%20gemcitabine%20in%20combination%20with%20regional%20arterial%20infusion%20of%20nafamostat%20mesilate%20for%20advanced%20pancreatic%20cancer&journal=Am%20J%20Clin%20Oncol&doi=10.1097%2FCOC.0b013e31823a53b2&publication_year=2011&author=Uwagawa%2CT&author=Misawa%2CT&author=Tsutsui%2CN generate monthly?
- https://doi.org/10.1097%2FMPA.0b013e31820b9257's financial summary
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21343836 generate monthly?
- What are the total earnings of http://scholar.google.com/scholar_lookup?&title=Combination%20paclitaxel%20and%20inhibitor%20of%20nuclear%20factor%20%CE%BAB%20activation%20improves%20therapeutic%20outcome%20for%20model%20mice%20with%20peritoneal%20dissemination%20of%20pancreatic%20cancer&journal=Pancreas&doi=10.1097%2FMPA.0b013e31820b9257&volume=40&pages=600-607&publication_year=2011&author=Fujiwara%2CY&author=Furukawa%2CK&author=Shimada%2CY?
- Explore the financials of https://doi.org/10.1016%2Fj.ab.2008.02.031
- Explore the financials of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18358228
- Check the income stats for http://scholar.google.com/scholar_lookup?&title=A%20protocol%20for%20immunoaffinity%20separation%20of%20the%20accumulated%20ubiquitin-protein%20conjugates%20solubilized%20with%20sodium%20dodecyl%20sulfate&journal=Anal%20Biochem&doi=10.1016%2Fj.ab.2008.02.031&volume=377&pages=77-82&publication_year=2008&author=Shimada%2CY&author=Fukuda%2CT&author=Aoki%2CK
- What are the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=6116707?
- How much does http://scholar.google.com/scholar_lookup?&title=Taxol-induced%20polymerization%20of%20purified%20tubulin%3A%20mechanism%20of%20action&journal=J%20Biol%20Chem&volume=256&pages=10435-10441&publication_year=1981&author=Kumar%2CN generate monthly?
- What is the earnings of https://doi.org/10.1021%2Fbi00514a041?
- What's the financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=6113842?
- How much income is http://scholar.google.com/scholar_lookup?&title=Taxol%20assembles%20tubulin%20in%20the%20absence%20of%20exogenous%20guanosine%205%E2%80%B2-triphosphate%20or%20microtubule-associated%20proteins&journal=Biochemistry&doi=10.1021%2Fbi00514a041&volume=20&pages=3247-3252&publication_year=1981&author=Schiff%2CPB&author=Horwitz%2CSB earning monthly?
- Learn about the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=2898289
- What is the monthly revenue of http://scholar.google.com/scholar_lookup?&title=Microtubule%20changes%20and%20cytotoxicity%20in%20leukemic%20cell%20lines%20treated%20with%20Taxol&journal=Cancer%20Res&volume=48&pages=4093-4100&publication_year=1988&author=Rowinsky%2CEK&author=Donehower%2CRC&author=Jones%2CRJ?
- What is the earnings of https://doi.org/10.1038%2F277665a0?
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=423966 generate?
- Get to know http://scholar.google.com/scholar_lookup?&title=Promotion%20of%20microtubule%20assembly%20in%20vitro%20by%20Taxol&journal=Nature&doi=10.1038%2F277665a0&volume=277&pages=665-667&publication_year=1979&author=Schiff%2CPB&author=Faut%2CJ&author=Horwitz%2CSB's earnings
- How profitable is https://doi.org/10.1016%2F0165-6147%2892%2990048-B?
- Monthly income for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=1350385
- What's the financial gain of http://scholar.google.com/scholar_lookup?&title=Mechanism%20of%20action%20taxol&journal=Trends%20Pharmacol%20Sci&doi=10.1016%2F0165-6147%2892%2990048-B&volume=13&pages=134-136&publication_year=1992&author=Horwitz%2CSB?
- Profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=8849943
- Discover the revenue of http://scholar.google.com/scholar_lookup?&title=Peritoneal-plasma%20barrier&journal=Cancer%20Treat%20Res&doi=10.1007%2F978-1-4613-1247-5_4&volume=82&pages=53-63&publication_year=1996&author=Jacquet%2CP&author=Sugarbaker%2CPH
- How profitable is https://doi.org/10.1016%2FS0140-6736%2894%2990754-4?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=7967989 pull in monthly?
- What are the total earnings of http://scholar.google.com/scholar_lookup?&title=The%20taxoids%3A%20paclitaxel%20and%20docetaxel&journal=Lancet&doi=10.1016%2FS0140-6736%2894%2990754-4&volume=344&pages=1267-1272&publication_year=1994&author=Gelmon%2CK?
- Learn how profitable https://doi.org/10.1016%2F0305-7372%2886%2990007-1 is on a monthly basis
- Learn how profitable http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=3545463 is on a monthly basis
- See how much http://scholar.google.com/scholar_lookup?&title=Intraperitoneal%20antineoplastic%20agents%20for%20tumors%20principally%20confined%20to%20the%20peritoneal%20cavity&journal=Cancer%20Treat%20Rev&doi=10.1016%2F0305-7372%2886%2990007-1&volume=13&pages=219-242&publication_year=1986&author=Markman%2CM makes per month
- How much profit does https://doi.org/10.1002%2F%28SICI%291097-0142%2819960101%2977%3A1%3C14%3A%3AAID-CNCR4%3E3.0.CO%3B2-N make?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=8630921 rake in every month?
- Earnings of http://scholar.google.com/scholar_lookup?&title=Paclitaxel-induced%20apoptosis%20in%20human%20gastric%20carcinoma%20cell%20lines&journal=Cancer&doi=10.1002%2F%28SICI%291097-0142%2819960101%2977%3A1%3C14%3A%3AAID-CNCR4%3E3.0.CO%3B2-N&volume=77&pages=14-18&publication_year=1996&author=Chang%2CYF&author=Li%2CLL&author=Wu%2CCW
- How much does https://doi.org/10.1126%2Fscience.281.5383.1680 pull in monthly?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9733516 generate monthly?
- How much does http://scholar.google.com/scholar_lookup?&title=NF-kappaB%20antiapoptosis%3A%20induction%20of%20TRAF1%20and%20TRAF2%20and%20c-IAP1%20and%20c-IAP2%20to%20suppress%20caspase-8%20activation&journal=Science&doi=10.1126%2Fscience.281.5383.1680&volume=281&pages=1680-1683&publication_year=1998&author=Wang%2CCY&author=Mayo%2CMW&author=Korneluk%2CRG earn?
- How much does https://doi.org/10.1158%2F1078-0432.CCR-04-0958 make?
- How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15569997 generate?
- Check the income stats for http://scholar.google.com/scholar_lookup?&title=Inhibition%20of%20inhibitor%20of%20nuclear%20factor-kappaB%20phosphorylation%20increases%20the%20efficacy%20of%20paclitaxel%20in%20in%20vitro%20and%20in%20vivo%20ovarian%20cancer%20models&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-04-0958&volume=10&pages=7645-7654&publication_year=2004&author=Mabuchi%2CS&author=Ohmichi%2CM&author=Nishio%2CY
- How much does https://doi.org/10.1158%2F1078-0432.CCR-05-1192 net monthly?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16243823 net monthly?
- How much does http://scholar.google.com/scholar_lookup?&title=Curcumin%20suppresses%20the%20paclitaxel-induced%20nuclear%20factor-kappaB%20pathway%20in%20breast%20cancer%20cells%20and%20inhibits%20lung%20metastasis%20of%20human%20breast%20cancer%20in%20nude%20mice&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-05-1192&volume=11&pages=7490-7498&publication_year=2005&author=Aggarwal%2CBB&author=Shishodia%2CS&author=Takada%2CY rake in every month?
- Revenue of https://doi.org/10.1002%2Fijc.23867
- How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18798274 make?
- What's the monthly money flow for http://scholar.google.com/scholar_lookup?&title=Intraperitoneal%20administration%20of%20a%20small%20interfering%20RNA%20targeting%20nuclear%20factor-kappa%20B%20with%20paclitaxel%20successfully%20prolongs%20the%20survival%20of%20xenograft%20model%20mice%20with%20peritoneal%20metastasis%20of%20gastric%20cancer&journal=Int%20J%20Cancer&doi=10.1002%2Fijc.23867&volume=123&pages=2696-2701&publication_year=2008&author=Inoue%2CM&author=Matsumoto%2CS&author=Saito%2CH?
- How much does https://citation-needed.springer.com/v2/references/10.1007/s10620-012-2311-4?format=refman&flavour=references net monthly?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Koichiro%20Haruki gross monthly?
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Koichiro%20Haruki%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en make?
- Check the income stats for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Hiroaki%20Shiba
- How much revenue does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Hiroaki%20Shiba%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en produce monthly?
- How much cash flow does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Yuki%20Fujiwara have monthly?
- Revenue of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Yuki%20Fujiwara%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- How much profit does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Kenei%20Furukawa generate?
- What is the earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Kenei%20Furukawa%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- Get to know https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Ryota%20Iwase's earnings
- What's the income of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Ryota%20Iwase%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Tadashi%20Uwagawa's total income per month
- Profit of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Tadashi%20Uwagawa%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- Profit of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Takeyuki%20Misawa
- What's the financial gain of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Takeyuki%20Misawa%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- What is the monthly revenue of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Toya%20Ohashi?
- Monthly income for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Toya%20Ohashi%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- What are the total earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Katsuhiko%20Yanaga?
- Earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Katsuhiko%20Yanaga%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- What's the financial gain of https://s100.copyright.com/AppDispatchServlet?title=Inhibition%20of%20Nuclear%20Factor-%CE%BAB%20Enhances%20the%20Antitumor%20Effect%20of%20Paclitaxel%20Against%20Gastric%20Cancer%20with%20Peritoneal%20Dissemination%20in%20Mice&author=Koichiro%20Haruki%20et%20al&contentID=10.1007%2Fs10620-012-2311-4©right=Springer%20Science%2BBusiness%20Media%2C%20LLC&publication=0163-2116&publicationDate=2012-07-18&publisherName=SpringerNature&orderBeanReset=true?
- How much profit does https://citation-needed.springer.com/v2/references/10.1007/s10620-012-2311-4?format=refman&flavour=citation generate?
- How much does https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral gross monthly?
- How much profit is https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research making per month?
- https://www.springernature.com/gp/products income
- What's the financial outcome of https://www.springernature.com/gp/librarians?
- Explore the financials of https://www.springernature.com/gp/societies
- How much does https://www.springernature.com/gp/partners bring in each month?
- How much profit does https://www.springer.com/ generate?
- What's the total monthly financial gain of https://www.nature.com/?
- https://www.biomedcentral.com/ income
- What is the monthly revenue of https://www.palgrave.com/?
- Profit of https://www.apress.com/
- https://www.springernature.com/gp/legal/ccpa's total income per month
- Income figures for https://www.springernature.com/gp/info/accessibility
- How much profit does https://support.springernature.com/en/support/home generate?
- How much does https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations pull in monthly?
- What's the total monthly financial gain of https://www.springernature.com/?
Analytics and Tracking {📊}
- Google Tag Manager
Libraries {📚}
- Clipboard.js
- Prism.js
CDN Services {📦}
- Crossref